Collegium Reports Second Quarter Financial Results and Provides Corporate Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
Collegium Pharma (COLL) Misses Q2 EPS by 16c
August 12, 2015 5:06 PM EDTCollegium Pharma (NASDAQ: COLL) reported Q2 EPS of ($0.45), $0.16 worse than the analyst estimate of ($0.29).
For earnings history and earnings-related data on Collegium Pharma (COLL) click here.
... More
